Stifel Downgrades Third Harmonic Bio (THRD) to Hold
Tweet Send to a Friend
Stifel analyst Alex Thompson downgraded Third Harmonic Bio (NASDAQ: THRD) from Buy to Hold with a price target of $5.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


